Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Feb;54(2):103–107. doi: 10.1136/thx.54.2.103

Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long term treatment with inhaled corticosteroids

P Brand 1, E Duiverman 1, H Waalkens 1, E E M van Essen-Zandvli 1, K Kerrebijn 1, D the 1
PMCID: PMC1745411  PMID: 10325912

Abstract

BACKGROUND—Guidelines for asthma management focus on treatment with inhaled corticosteroids and on home recording of peak expiratory flow (PEF). The effect of maintenance treatment with inhaled corticosteroids on PEF variation and its relation to other parameters of disease activity were examined in 102 asthmatic children aged 7-14 years.
METHODS—During 20 months of treatment with inhaled salbutamol, with or without inhaled budesonide (600 µg daily), forced expiratory volume in one second (FEV1), the dose of histamine required to provoke a fall in FEV1 of more than 20% (PD20), the percentage of symptom free days, and PEF variation were assessed bimonthly. PEF variation was computed as the lowest PEF as a percentage of the highest PEF occurring over 14 days, the usual way of expressing PEF variation in asthma self-management plans. For each patient using inhaled corticosteroids within subject correlation coefficients (ρ) were computed of PEF variation to the percentage of symptom free days, FEV1, and PD20.
RESULTS—PEF variation decreased significantly during the first two months of treatment with inhaled corticosteroids and then remained stable. The same pattern was observed for symptoms and FEV1. In contrast, PD20 histamine continued to improve throughout the whole follow up period. In individual patients predominantly positive associations of PEF variation with symptoms, FEV1, and PD20 were found, but the ranges of these associations were wide.
CONCLUSIONS—During treatment with inhaled corticosteroids the changes in PEF variation over time show poor concordance with changes in other parameters of asthma severity. When only PEF is monitored, clinically relevant deteriorations in symptoms, FEV1, or PD20 may be missed. This suggests that home recording of PEF alone may not be sufficient to monitor asthma severity reliably in children.



Full Text

The Full Text of this article is available as a PDF (158.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brand P. L., Duiverman E. J., Postma D. S., Waalkens H. J., Kerrebijn K. F., van Essen-Zandvliet E. E. Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness. Dutch CNSLD Study Group. Eur Respir J. 1997 Jun;10(6):1242–1247. doi: 10.1183/09031936.97.10061242. [DOI] [PubMed] [Google Scholar]
  2. Brand P. L., Waalkens H. J., Duiverman E. J., van Essen-Zandvliet E. E. Inaccuracy of portable peak flow meters: correction is not needed. Dutch CNSLD Study Group. Acta Paediatr. 1997 Aug;86(8):888–889. doi: 10.1111/j.1651-2227.1997.tb08616.x. [DOI] [PubMed] [Google Scholar]
  3. Brewis R. A. Patient education, self-management plans and peak flow measurement. Respir Med. 1991 Nov;85(6):457–462. doi: 10.1016/s0954-6111(06)80262-3. [DOI] [PubMed] [Google Scholar]
  4. Calpin C., Macarthur C., Stephens D., Feldman W., Parkin P. C. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature. J Allergy Clin Immunol. 1997 Oct;100(4):452–457. doi: 10.1016/s0091-6749(97)70134-9. [DOI] [PubMed] [Google Scholar]
  5. Cazzola G., Amalfitano G., Tonolli E., Perazzoli C., Piacentini I., Mastella G. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Acta Paediatr. 1996 May;85(5):554–557. doi: 10.1111/j.1651-2227.1996.tb14085.x. [DOI] [PubMed] [Google Scholar]
  6. Charlton I., Antoniou A. G., Atkinson J., Campbell M. J., Chapman E., Mackintosh T., Schapira D. Asthma at the interface: bridging the gap between general practice and a district general hospital. Arch Dis Child. 1994 Apr;70(4):313–318. doi: 10.1136/adc.70.4.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cifu D. X., Kreutzer J. S., Marwitz J. H., Miller M., Hsu G. M., Seel R. T., Englander J., High W. M., Jr, Zafonte R. Etiology and incidence of rehospitalization after traumatic brain injury: a multicenter analysis. Arch Phys Med Rehabil. 1999 Jan;80(1):85–90. doi: 10.1016/s0003-9993(99)90312-x. [DOI] [PubMed] [Google Scholar]
  8. Clough J. B., Holgate S. T. Episodes of respiratory morbidity in children with cough and wheeze. Am J Respir Crit Care Med. 1994 Jul;150(1):48–53. doi: 10.1164/ajrccm.150.1.8025771. [DOI] [PubMed] [Google Scholar]
  9. Clough J. B., Sly P. D. Association between lower respiratory tract symptoms and falls in peak expiratory flow in children. Eur Respir J. 1995 May;8(5):718–722. [PubMed] [Google Scholar]
  10. Clough J. B., Williams J. D., Holgate S. T. Effect of atopy on the natural history of symptoms, peak expiratory flow, and bronchial responsiveness in 7- and 8-year-old children with cough and wheeze. A 12-month longitudinal study [published errarum appears in Am Rev Respir Dis 1992 Aug;146(2):540]. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):755–760. doi: 10.1164/ajrccm/143.4_Pt_1.755. [DOI] [PubMed] [Google Scholar]
  11. Doull I. J., Lampe F. C., Smith S., Schreiber J., Freezer N. J., Holgate S. T. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ. 1997 Oct 4;315(7112):858–862. doi: 10.1136/bmj.315.7112.858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Frischer T., Meinert R., Urbanek R., Kuehr J. Variability of peak expiratory flow rate in children: short and long term reproducibility. Thorax. 1995 Jan;50(1):35–39. doi: 10.1136/thx.50.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gern J. E., Eggleston P. A., Schuberth K. C., Eney N. D., Goldstein E. O., Weiss M. E., Adkinson N. F., Jr Peak flow variation in childhood asthma: a three-year analysis. J Allergy Clin Immunol. 1994 Apr;93(4):706–716. doi: 10.1016/0091-6749(94)90250-x. [DOI] [PubMed] [Google Scholar]
  14. Madge P., McColl J., Paton J. Impact of a nurse-led home management training programme in children admitted to hospital with acute asthma: a randomised controlled study. Thorax. 1997 Mar;52(3):223–228. doi: 10.1136/thx.52.3.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miller M. R., Dickinson S. A., Hitchings D. J. The accuracy of portable peak flow meters. Thorax. 1992 Nov;47(11):904–909. doi: 10.1136/thx.47.11.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Reddel H. K., Salome C. M., Peat J. K., Woolcock A. J. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med. 1995 May;151(5):1320–1325. doi: 10.1164/ajrccm.151.5.7735580. [DOI] [PubMed] [Google Scholar]
  17. Ronchetti R., Indinnimeo L., Bonci E., Corrias A., Evans D., Hindi-Alexander M., Midulla F., Pulejo R., Villa M. P. Asthma self-management programmes in a population of Italian children: a multicentric study. Italian Study Group on Asthma Self-Management Programmes. Eur Respir J. 1997 Jun;10(6):1248–1253. doi: 10.1183/09031936.97.10061248. [DOI] [PubMed] [Google Scholar]
  18. Siersted H. C., Hansen H. S., Hansen N. C., Hyldebrandt N., Mostgaard G., Oxhøj H. Evaluation of peak expiratory flow variability in an adolescent population sample. The Odense Schoolchild Study. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):598–603. doi: 10.1164/ajrccm.149.3.8118624. [DOI] [PubMed] [Google Scholar]
  19. Simons F. E. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med. 1997 Dec 4;337(23):1659–1665. doi: 10.1056/NEJM199712043372304. [DOI] [PubMed] [Google Scholar]
  20. Sly P. D., Cahill P., Willet K., Burton P. Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma. BMJ. 1994 Feb 26;308(6928):572–574. doi: 10.1136/bmj.308.6928.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Taylor M. R. Asthma: audit of peak flow rate guidelines for admission and discharge. Arch Dis Child. 1994 May;70(5):432–434. doi: 10.1136/adc.70.5.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Toogood J. H., Andreou P., Baskerville J. A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations. J Allergy Clin Immunol. 1996 Sep;98(3):555–562. doi: 10.1016/s0091-6749(96)70089-1. [DOI] [PubMed] [Google Scholar]
  23. Turner M. O., Taylor D., Bennett R., Fitzgerald J. M. A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med. 1998 Feb;157(2):540–546. doi: 10.1164/ajrccm.157.2.9703060. [DOI] [PubMed] [Google Scholar]
  24. Uwyyed K., Springer C., Avital A., Bar-Yishay E., Godfrey S. Home recording of PEF in young asthmatics: does it contribute to management? Eur Respir J. 1996 May;9(5):872–879. doi: 10.1183/09031936.96.09050872. [DOI] [PubMed] [Google Scholar]
  25. Waalkens H. J., Gerritsen J., Koëter G. H., Krouwels F. H., van Aalderen W. M., Knol K. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow. Thorax. 1991 Jul;46(7):499–503. doi: 10.1136/thx.46.7.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van Essen-Zandvliet E. E., Hughes M. D., Waalkens H. J., Duiverman E. J., Pocock S. J., Kerrebijn K. F. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis. 1992 Sep;146(3):547–554. doi: 10.1164/ajrccm/146.3.547. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES